Search results
Johnson & Johnson Advances Its Two Bladder Cancer Studies, Releases Latest Data
Benzinga· 2 hours agoResults featured updated data from Cohort 1 (C1), patients with recurrent, Bacillus Calmette-Guérin...
TAR-210 results show 90% recurrence-free survival and 90% complete response in patients with high...
KFDX Wichita Falls· 1 day agoResults featured updated data from Cohort 1 (C1), patients with recurrent, Bacillus Calmette-Guérin...
Breast cancer screening task force makes changes that impact women in their 40s
CBS 6 Richmond· 2 hours agoRegular mammograms to screen for breast cancer should start younger, at age 40, according to an...
Winfield's Abby Brown forges on through cancer battle, friend's death: Scholar Athlete spotlight
St. Louis Post-Dispatch· 11 hours agoEditor's note: A special section recognizing the 58th edition of Post-Dispatch Scholar Athletes...
Johnson & Johnson reports data from Phase II prostate cancer trial
Clinical Trials Arena via Yahoo Finance· 14 hours agoThe single-arm, open-label, multicentre study involved 108 subjects...Treatment-emergent adverse...
How NBA athletes are aiding the fight against racial health inequality
theGrio via AOL· 47 minutes agoThe post How NBA athletes are aiding the fight against racial health inequality appeared first on...
Nine Florida students won cash in art contest on sun safety, winners announced
Palm Beach Daily News via Yahoo News· 3 hours agoWhat is melanoma? Melanoma is one of the least common but most dangerous types of skin cancer because “it’s much more likely to spread to other parts of the body if not found ...
Brain cancer in children is notoriously hard to treat – a new mRNAcancer vaccine triggers an attack...
The Conversation· 6 days agoBrain cancers remain among the most challenging tumors to treat. As a result, brain cancer is the leading cause of cancer-related death ...
Correct Dx of Cancer Treatment Skin Effects Evaluated
Medscape· 17 hours agoCompared with medical oncologists, dermatologists were more likely to correctly classify and grade dermatologic adverse events from cancer therapies, results ...
TAR-200 monotherapy shows greater than 80% complete response rate in patients with high-risk...
WKRN Nashville· 3 days ago"The high complete response rate and durability of these responses observed in patients treated with TAR-200 underscores the potential of this treatment...